These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 2 of 4 substances referred to collectively as the Stilbenes Group.
|Substance group||CAS RN||Common name||DSL name||Public comments on the draft screening assessment||Final screening assessment||Conclusion on section 64 criteria||Follow-up activities|
|Stilbenes Group||4193-55-9||C.I. Fluorescent Brightener 28, disodium salt||Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt||HTML||HTML||Does not meet||None planned at this time|
|16090-02-1||Fluorescent Brightener FWA-1||Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-(4-morpholinyl)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt|
|February 2, 2019||Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 5.|
|September 30, 2017||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 39.|
Two other substances (CAS RNs 1533-45-5 and 3426-43-5) were identified as being part of the Stilbenes Group at the outset of the third phase of the CMP. These substances were subsequently determined to be of low concern to both human health and the environment, through other approaches. Conclusions for these two substances are provided in the Screening Assessment for the Rapid Screening of Substances with Limited General Population Exposure.
Report a problem or mistake on this page
- Date modified: